Ghislaine Gilleron
Nessuna posizione attualmente
Profilo
Ghislaine Gilleron is the founder of ElsaLys Biotech SAS, which was founded in 2013.
She worked as a Director at MiddleNext and as General Secretary & General Counsel at Transgene SA in 1985.
Ms. Gilleron completed her undergraduate degree at Institut d'Études Politiques d'Aix-en-Provence.
Precedenti posizioni note di Ghislaine Gilleron
| Società | Posizione | Fine |
|---|---|---|
MiddleNext
 MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | - |
| ELSALYS BIOTECH | Fondatore | - |
| TRANSGENE | Consigliere Generale | 01/01/1985 |
Formazione di Ghislaine Gilleron
| Institut d'Études Politiques d'Aix-en-Provence | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Aziende private | 2 |
|---|---|
MiddleNext
MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Commercial Services |
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Borsa valori
- Insiders
- Ghislaine Gilleron
